Associated Papers
Genotypes of SNPs of key genes regulate susceptibility and drug sensitivity to neovascular AMD in the human population.
Cui J et al.
Bmj Open Ophthalmology, 2025
ANXA5 and VEGFA Gene Variants in Women with Early Pregnancy Losses from North Macedonia.
Terzikj M et al.
Balkan Journal of Medical Genetics : Bjmg, 2024
Genetic susceptibility of bladder cancer in the Lebanese population.
Kourie HR et al.
Bmc Medical Genomics, 2022
36253817 (PubMed )
Supplement: 12920_2022_1372_MOESM1_ESM.xlsx › sheet_1
Pharmacogenomics, biomarker network, and allele frequencies in colorectal cancer.
López-Cortés A et al.
The Pharmacogenomics Journal, 2020
MTHFR and F5 genetic variations have association with preeclampsia in Pakistani patients: a case control study.
Khidri FF et al.
Bmc Medical Genetics, 2019
Prognostic effect of VEGF gene variants in metastatic non-small-cell lung cancer patients.
Sullivan I et al.
Angiogenesis, 2019
PTPRT and PTPRD Deleterious Mutations and Deletion Predict Bevacizumab Resistance in Metastatic Colorectal Cancer Patients.
Hsu HC et al.
Cancers, 2018
Identification of PGF as a New Gene for Neovascular Age-Related Macular Degeneration in a Chinese Population.
Chen LJ et al.
Investigative Ophthalmology & Visual Science, 2016
Genetic association study of coronary collateral circulation in patients with coronary artery disease using 22 single nucleotide polymorphisms corresponding to 10 genes involved in postischemic neovascularization.
Duran J et al.
Bmc Cardiovascular Disorders, 2015
Vascular Endothelial Growth Factor A c.*237C>T polymorphism is associated with bevacizumab efficacy and related hypertension in metastatic colorectal cancer.
Sibertin-Blanc C et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2015
Vascular endothelial growth factor single-nucleotide polymorphism in gallbladder cancer.
Mishra K et al.
Journal of Gastroenterology and Hepatology, 2013
The association of 18F-deoxyglucose (FDG) uptake of PET with polymorphisms in the glucose transporter gene (SLC2A1) and hypoxia-related genes (HIF1A, VEGFA, APEX1) in non-small cell lung cancer. SLC2A1 polymorphisms and FDG-PET in NSCLC patients.
Kim SJ et al.
Journal of Experimental & Clinical Cancer Research : Cr, 2010
Select a paper to view details